The Gary Null Show - 02.15.22

Alpha-lipoic acid supplementation associated with improved lipid levels   Tabriz University of Medical Sciences (Iran), February 14 2022.    Findings from a systematic review and meta-analysis published in the International Journal for Vitamin and Nutrition Research indicated that supplementing with alpha-lipoic acid was associated with improvements in total cholesterol, low-density lipoprotein (LDL) cholesterol and triglycerides. Researchers at Tabriz university of Medical Sciences in Iran selected 12 randomized, placebo-controlled trials that evaluated the association between supplementing with alpha-lipoic acid and lipid levels among a total of 548 participants.  Analysis of all 12 studies (which included data concerning triglycerides) found a significant reduction in triglycerides in association with alpha-lipoic acid. Dose-response analysis found a nonlinear relationship of LDL cholesterol and triglyceride levels with alpha-lipoic acid dosage that was dependent upon the duration of treatment.   (NEXT)   Positive attitudes about aging reduce risk of dementia in older adults   Yale University, February 7, 2022   Research has shown that older persons who have acquired positive beliefs about old age from their surrounding culture are less likely to develop dementia. This protective effect was found for all participants, as well as among those carrying a gene that puts them at higher risk of developing dementia, a new study led by the Yale School of Public Health has found. Published in the journal PLOS ONE, the study reports that older persons with positive age beliefs who carry one of the strongest risk factors for developing dementia—the ε4 variant of the APOE gene —were nearly 50% less likely to develop the disease than their peers who held negative age beliefs.   (NEXT)   Study: Running helps brain stave off effects of chronic stress   Exercise protects vital memory and learning functions Brigham Young University, February 14, 2022   Most people agree that getting a little exercise helps when dealing with stress. A new BYU study discovers exercise -- particularly running -- while under stress also helps protect your memory. The study, newly published in the journal of Neurobiology of Learning and Memory, finds that running mitigates the negative impacts chronic stress has on the hippocampus, the part of the brain responsible for learning and memory. "Exercise is a simple and cost-effective way to eliminate the negative impacts on memory of chronic stress," said study lead author Jeff Edwards, associate professor of physiology and developmental biology at BYU. Inside the hippocampus, memory formation and recall occur optimally when the synapses or connections between neurons are strengthened over time. That process of synaptic strengthening is called long-term potentiation (LTP). Chronic or prolonged stress weakens the synapses, which decreases LTP and ultimately impacts memory. Edwards' study found that when exercise co-occurs with stress, LTP levels are not decreased, but remain normal.   (NEXT)   Extra Virgin Olive Oil: Why It’s Healthier Than Other Cooking Oils   University of Hertfordshire (UK), February 14, 2022   Numerous studies have shown that consuming olive oil – in particular extra virgin olive oil (EVOO) – can have many different benefits for our health. For example, the Spanish PREDIMED study (the largest randomised control trial ever conducted on the Mediterranean diet) showed that women who ate a Mediterranean diet supplemented with extra virgin olive oil had a 62% lower risk of breast cancer compared to women who were advised to eat a low-fat diet. Experts who have since examined multiple scientific studies looking at the Mediterranean diet and its effect on chronic diseases conclude that a primary reason the diet protects against breast cancer is because of EVOO. There’s also evidence that EVOO may protect against type 2 diabetes and possibly even Alzheimer’s disease. Alongside its fat, EVOO contains many natural substances, such as polyphenols. Polyphenols occur naturally in plants, and have been linked to many health benefits, such as reducing the risk of cardiovascular disease and cognitive disorders.   (OTHER NEWS)   EXCLUSIVE: Embalmer reveals 93% of cases died from the vaccine   Anna Foster is an embalmer with 11 years of experience in Carrollton, MO. She reveals that 93% of her last 30 cases died due to clots from the COVID vaccine.   Steve Kirsch, February 14, 2022   Anna Foster is an embalmer with 11 years of experience in Carrollton, MO. She speaks out for the first time The big news is that she found the unusual clots in 93% of the last 30 people who she embalmed. This is significant because she isn’t selective about who she embalms. Not all embalmers will see a 93% clot rate. Richard Hirschman only sees these clots in 65% of his cases. Either way, we have identified what is the #1 cause of death in America today; a killer that is much bigger than COVID. This is a massive health issue since it is killing a huge number of people. Her embalmer friends have noticed it as well and have never seen it before in their careers. The clots are only associated with people who have been vaccinated. They were only observed after the vaccines rolled out. The clots are life threatening and are almost certainly the root cause of death in all of these cases. When 93% of people who die are killed by a single cause, this merits immediate investigation by the CDC as to the cause. However, I am certain that the CDC and all legacy media will continue to ignore this story.   (NEXT)   Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021   Centers for Disease Control and Prevention, Emory University, Vanderbilt University, Boston Medical Center, Duke University, US Food and Drug Administration   Journal of American Medical Association, February 2022   Question  What is the risk of myocarditis after mRNA-based COVID-19 vaccination in the US? Findings  In this descriptive study of 1626 cases of myocarditis in a national passive reporting system, the crude reporting rates within 7 days after vaccination exceeded the expected rates across multiple age and sex strata. The rates of myocarditis cases were highest after the second vaccination dose in adolescent males aged 12 to 15 years ), in adolescent males aged 16 to 17 years , and in young men aged 18 to 24 years . Results  Among 192 405 448 persons receiving a total of 354 100 845 mRNA-based COVID-19 vaccines during the study period, there were 1991 reports of myocarditis to VAERS and 1626 of these reports met the case definition of myocarditis. Of those with myocarditis, the median age was 21 years (IQR, 16-31 years) and the median time to symptom onset was 2 days (IQR, 1-3 days). Males comprised 82% of the myocarditis cases for whom sex was reported. The crude reporting rates for cases of myocarditis within 7 days after COVID-19 vaccination exceeded the expected rates of myocarditis across multiple age and sex strata. The rates of myocarditis were highest after the second vaccination dose in adolescent males aged 12 to 15 years (70.7 per million doses of the BNT162b2 vaccine), in adolescent males aged 16 to 17 years (105.9 per million doses of the BNT162b2 vaccine), and in young men aged 18 to 24 years (52.4 and 56.3 per million doses of the BNT162b2 vaccine and the mRNA-1273 vaccine, respectively). There were 826 cases of myocarditis among those younger than 30 years of age who had detailed clinical information available; of these cases, 792 of 809 (98%) had elevated troponin levels, 569 of 794 (72%) had abnormal electrocardiogram results, and 223 of 312 (72%) had abnormal cardiac magnetic resonance imaging results. Approximately 96% of persons (784/813) were hospitalized and 87% (577/661) of these had resolution of presenting symptoms by hospital discharge. The most common treatment was nonsteroidal anti-inflammatory drugs (589/676; 87%). Conclusions and Relevance  Based on passive surveillance reporting in the US, the risk of myocarditis after receiving mRNA-based COVID-19 vaccines was increased across multiple age and sex strata and was highest after the second vaccination dose in adolescent males and young men. This risk should be considered in the context of the benefits of COVID-19 vaccination.